IL15 and neoplasm: Recently, using a model involving transplantation and surgical resection of the murine MHC-I+Rae1b+ breast cancer line, EO771 showed that administering IL-15/IL-12-conditioned syngeneic NK cells following primary tumor removal enhanced the long-term survival of mice with minimal metastatic spread [16].